Antibody efficacy of inactivated vaccine boosters (CoronaVac) against Omicron variant from a 15-month follow-up study

J Infect. 2022 Oct;85(4):e119-e121. doi: 10.1016/j.jinf.2022.06.018. Epub 2022 Jun 26.

Authors

Yue Yin¹, Xinjie Li¹, Chungen Qian², Bangning Cheng², Fengmin Lu¹, Tao Shen³

Affiliations

¹ Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing, China.
² Peking University - YHLO Joint Laboratory for Molecular Diagnostics of Infectious Diseases, Peking University, Beijing, China.
³ Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing, China. Electronic address: taoshen@hsc.pku.edu.cn.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antibodies*
Antibodies, Neutralizing
Antibodies, Viral
COVID-19 Vaccines*
Follow-Up Studies
Humans
Immunization, Secondary
Vaccines, Inactivated

Substances

Antibodies
Antibodies, Neutralizing
Antibodies, Viral
COVID-19 Vaccines
Vaccines, Inactivated